Goodman & Nekvasil, P.A., May Recover Investor Losses – Rockwell Medical, Inc. (RMTI)
Rockwell Medical, Inc. (RMTI) operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally, according to Yahoo Finance. On May 23, 2018 Nasdaq announced that trading of Rockwell Medical, Inc. (RMTI) was halted and that the trading halt status was changed to “additional information requested” from the company. According to Reuters, On May 22, 2018 the board of directors of Rockwell Medical, Inc. (RMTI) announced that President and CEO, Robert Chioini, has been terminated from his positions, effective immediately.
Goodman & Nekvasil, P.A., a Clearwater, Florida, law firm with a national practice representing victimized investors, continues to investigate brokerage firms that placed elderly retirees and other conservative investors in high-risk investments such as Rockwell Medical, Inc. (RMTI).
Goodman & Nekvasil, P.A., has filed hundreds of cases against brokerage firms selling high-risk investments such as Rockwell Medical, Inc. (RMTI) and has recovered more than $180 million dollars on behalf of victimized investors. We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives. All our cases are handled on a purely contingency fee basis.
You may have the right to recover your losses from the brokerage firm that sold Rockwell Medical, Inc. (RMTI) and other high-risk investments to you. We strongly recommend that you act quickly, however, because statutes of limitation can be short in securities cases.
Kalju Nekvasil, Esq., formerly regional counsel with the NASD, now known as FINRA, has practiced in this area of the law for more than 35 years. We would like to discuss the possibility of your retaining our firm to represent you in an arbitration action.
There is no charge for an evaluation of your case. Further, we handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee. Unless you recover any money, you pay us nothing, not even the costs and expenses which the firm will advance on your behalf. Finally, the filing of such a case should not affect your ownership of these investments in any way.
If you incurred losses on your investment in Rockwell Medical, Inc. (RMTI) and/or other high-risk investments and would like your case evaluated by a securities attorney (again, there is no charge for an evaluation and all cases are handled on a purely contingency fee basis), please contact us.
Keywords: Rockwell Medical, Inc., RMTI, Nasdaq, FINRA, Stock, Investment, NASD, SEC, Fraud, Attorney, Broker, Brokerage, Firm, Brokerage Firm, Invest, Lawyer, Securities Lawyer, Goodman and Nekvasil, Nekvasil, Goodman, Investor, Investment, Financial, Financial Services, Securities